Showing results (101-110 of 715) with videos related to
Sort By:
Pageof 72
Seminars in Oncology|March 3, 2011
The evolution of imaging in cancer: current state and future challengesLuke J Higgins, Martin G PomperEuropean Journal of Nuclear Medicine and Molecular Imaging|August 11, 2019
177Lu-labeled low-molecular-weight agents for PSMA-targeted radiopharmaceutical therapySangeeta Ray Banerjee, Vivek Kumar, Ala Lisok, et al.EJNMMI Research|August 26, 2024
A radioligand for in vitro autoradiography of CSF1R in post-mortem CNS tissuesCatherine A Foss, Ravi Naik, Deepankar Das, et al.EJNMMI Radiopharmacy and Chemistry|January 11, 2026
Fluorine-18-labeled PET radiotracers for imaging the macrophage colony-stimulating factor 1 receptor (CSF1R)Deepankar Das, Hyojin Cha, Ravi Naik, et al.The Journal of Urology|April 7, 2020
Prostate Specific Antigen and Prostate Specific Antigen Doubling Time Predict Findings on 18F-DCFPyL Positron Emission Tomography/Computerized Tomography in Patients with Biochemically Recurrent Prostate CancerMark C Markowski, Ramy Sedhom, Wei Fu, et al.Theranostics|January 8, 2019
The theranostic promise for Neuroendocrine Tumors in the late 2010s - Where do we stand, where do we go?Rudolf A Werner, Alexander Weich, Malte Kircher, et al.Diagnostics (Basel, Switzerland)|April 30, 2021
Effect of Point-Spread Function Reconstruction for Indeterminate PSMA-RADS-3A Lesions on PSMA-Targeted PET Imaging of Men with Prostate CancerWajahat Khatri, Hyun Woo Chung, Rudolf A Werner, et al.Current Pharmaceutical Design|October 28, 2005
Small animal imaging in drug developmentMartin G Pomper, Jae Sung LeeNanomedicine (London, England)|March 18, 2026
Applying multimodal dendrimers for prostate cancer theranosticsWojciech G Lesniak, Martin G PomperTheranostics|March 21, 2020
Auger radiopharmaceutical therapy targeting prostate-specific membrane antigen in a micrometastatic model of prostate cancerColette J Shen, Il Minn, Robert F Hobbs, et al.Pageof 72